- Investing Ideas
- /
- Australian Pure Equity Growth
Australian Pure Equity Growth
Results
32
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
32 companies
Capricorn Metals
Market Cap: AU$6.6b
Explores, develops, evaluates, and produces gold in Australia.
CMM
AU$14.44
7D
-1.6%
1Y
123.2%
Capricorn Metals
Market Cap: AU$6.6b
Explores, develops, evaluates, and produces gold in Australia.
CMM
AU$14.43
7D
-1.8%
1Y
122.3%
Emerald Resources
Market Cap: AU$4.2b
Engages in the exploration and development of mineral reserves in Cambodia and Australia.
EMR
AU$6.36
7D
-1.2%
1Y
90.4%
Emerald Resources
Market Cap: AU$4.2b
Engages in the exploration and development of mineral reserves in Cambodia and Australia.
EMR
AU$6.33
7D
-1.2%
1Y
88.4%
Rox Resources
Market Cap: AU$648.4m
Engages in mineral exploration activities in Australia.
RXL
AU$0.48
7D
1.0%
1Y
142.5%
Rox Resources
Market Cap: AU$648.4m
Engages in mineral exploration activities in Australia.
RXL
AU$0.48
7D
1.0%
1Y
148.7%
Lotus Resources
Market Cap: AU$502.7m
Engages in the exploration and development of uranium projects in Africa.
LOT
AU$0.18
7D
0%
1Y
-21.3%
Lotus Resources
Market Cap: AU$502.7m
Engages in the exploration and development of uranium projects in Africa.
LOT
AU$0.18
7D
-2.6%
1Y
-21.3%
Peninsula Energy
Market Cap: AU$283.3m
Operates as a uranium exploration company in the United States.
PEN
AU$0.69
7D
6.1%
1Y
-52.6%
Peninsula Energy
Market Cap: AU$283.3m
Operates as a uranium exploration company in the United States.
PEN
AU$0.69
7D
6.9%
1Y
-52.7%
Botanix Pharmaceuticals
Market Cap: AU$265.7m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.14
7D
14.6%
1Y
-69.6%
Botanix Pharmaceuticals
Market Cap: AU$265.7m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.14
7D
12.5%
1Y
-70.0%
Echo IQ
Market Cap: AU$165.8m
Engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia.
EIQ
AU$0.26
7D
-3.8%
1Y
4.1%
Echo IQ
Market Cap: AU$165.8m
Engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia.
EIQ
AU$0.26
7D
-1.9%
1Y
4.1%
Sea Forest
Market Cap: AU$162.0m
Operates as a science-based feed additive manufacturer.
SEA
AU$2.89
7D
21.4%
1Y
n/a
Sea Forest
Market Cap: AU$162.0m
Operates as a science-based feed additive manufacturer.
SEA
AU$2.90
7D
16.9%
1Y
n/a
Adveritas
Market Cap: AU$129.4m
Provides funnel measurement, verification, and fraud prevention solutions for digital advertising in North America, Latin America, Asia Pacific, Australia, Europe, and internationally.
AV1
AU$0.14
7D
7.7%
1Y
48.9%
Adveritas
Market Cap: AU$129.4m
Provides funnel measurement, verification, and fraud prevention solutions for digital advertising in North America, Latin America, Asia Pacific, Australia, Europe, and internationally.
AV1
AU$0.14
7D
0%
1Y
51.7%
BlinkLab
Market Cap: AU$103.9m
Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.
BB1
AU$0.82
7D
2.5%
1Y
205.6%
BlinkLab
Market Cap: AU$103.9m
Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.
BB1
AU$0.83
7D
3.7%
1Y
209.3%
Lunnon Metals
Market Cap: AU$74.8m
Focuses on the exploration and development of nickel and gold in Australia.
LM8
AU$0.34
7D
9.8%
1Y
34.0%
Lunnon Metals
Market Cap: AU$74.8m
Focuses on the exploration and development of nickel and gold in Australia.
LM8
AU$0.34
7D
9.8%
1Y
36.7%
EZZ Life Science Holdings
Market Cap: AU$68.3m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$1.45
7D
3.6%
1Y
-52.9%
EZZ Life Science Holdings
Market Cap: AU$68.3m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$1.45
7D
4.1%
1Y
-52.2%
Vitasora Health
Market Cap: AU$42.7m
Researches, develops, and commercializes medical devices in Australia and the United States.
VHL
AU$0.023
7D
4.5%
1Y
-72.3%
Vitasora Health
Market Cap: AU$42.7m
Researches, develops, and commercializes medical devices in Australia and the United States.
VHL
AU$0.025
7D
13.6%
1Y
-68.4%
Nova Eye Medical
Market Cap: AU$39.9m
Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.
EYE
AU$0.14
7D
1.9%
1Y
-25.0%
Nova Eye Medical
Market Cap: AU$39.9m
Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.
EYE
AU$0.14
7D
3.7%
1Y
-22.2%
Pointerra
Market Cap: AU$31.5m
Provides a cloud-based solution for storing, processing, managing, analyzing, extracting, visualizing, and sharing 3D data in Australia and the United States.
3DP
AU$0.039
7D
2.6%
1Y
-7.1%
Pointerra
Market Cap: AU$31.5m
Provides a cloud-based solution for storing, processing, managing, analyzing, extracting, visualizing, and sharing 3D data in Australia and the United States.
3DP
AU$0.039
7D
2.6%
1Y
-7.1%
Pure One
Market Cap: AU$29.6m
Engages in the development of zero emissions vehicles and natural gas energy projects in Australia and Botswana.
P1E
AU$0.084
7D
0%
1Y
-23.6%
Pure One
Market Cap: AU$29.6m
Engages in the development of zero emissions vehicles and natural gas energy projects in Australia and Botswana.
P1E
AU$0.076
7D
-5.0%
1Y
-27.6%